A cocktail of protective antibodies subverts the dense glycan shield of Lassa virus
Authors:
- Haoyang LiHLHaoyang Li
- Tierra BuckTBTierra Buck
- Michelle ZandonattiMZMichelle Zandonatti
- Jieyun YinJYJieyun Yin
- Alex Moon-WalkerAMAlex Moon-Walker
- Jingru FangJFJingru Fang
- Megan L. HeinrichMHMegan L. Heinrich
- Megan M. RowlandMRMegan M. Rowland
- Ruben Diaz AvalosRARuben Diaz Avalos
- Sharon L. SchendelSSSharon L. Schendel
- Diptiben ParekhDPDiptiben Parekh
- 26 October 2022
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 14 (668) , eabq0991
Abstract
Developing potent therapeutics and effective vaccines are the ultimate goals in controlling infectious diseases. Lassa virus (LASV), the causative pathogen of Lassa fever (LF), infects hundreds of thousands annually, but effective antivirals or vaccines against LASV infection are still lacking. Furthermore, neutralizing antibodies against LASV are rare. Here, we describe biochemical analyses and high-resolution cryo-electron microscopy structures of a therapeutic cocktail of three broadly protective antibodies that target the LASV glycoprotein complex (GPC), previously identified from survivors of multiple LASV infections. Structural and mechanistic analyses reveal compatible neutralizing epitopes and complementary neutralization mechanisms that offer high potency, broad range, and resistance to escape. These antibodies either circumvent or exploit specific glycans comprising the extensive glycan shield of GPC. Further, they require mammalian glycosylation, native GPC cleavage, and proper GPC trimerization. These findings guided engineering of a next-generation GPC antigen suitable for future neutralizing antibody and vaccine discovery. Together, these results explain protective mechanisms of rare, broad, and potent antibodies and identify a strategy for the rational design of therapeutic modalities against LF and related infectious diseases.Keywords
This publication has 57 references indexed in Scilit:
- Lassa hemorrhagic fever in a late term pregnancy from northern sierra leone with a positive maternal outcome: case reportVirology Journal, 2011
- A general strategy for the evolution of bond-forming enzymes using yeast displayProceedings of the National Academy of Sciences, 2011
- PHENIX: a comprehensive Python-based system for macromolecular structure solutionActa Crystallographica Section D Structural Biology, 2010
- XDSActa Crystallographica Section D Structural Biology, 2010
- Phylogeny.fr: robust phylogenetic analysis for the non-specialistNucleic Acids Research, 2008
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004
- The Structural Basis for Methylmalonic AciduriaJournal of Biological Chemistry, 2004
- Expressed Murine and Human CDR-H3 Intervals of Equal Length Exhibit Distinct Repertoires that Differ in their Amino Acid Composition and Predicted Range of StructuresJournal of Molecular Biology, 2003
- Identification of α-Dystroglycan as a Receptor for Lymphocytic Choriomeningitis Virus and Lassa Fever VirusScience, 1998
- Lassa FeverNew England Journal of Medicine, 1986